Clinical trial
Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With…
NCT00493545 · Nventa Biopharmaceuticals Corporation, Industry · Unknown status
Key facts
| NCT number | NCT00493545 |
|---|---|
| Title | Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia |
| Official title | A Multicenter, Nonrandomized, Open-Label Phase 1 Safety Study of HspE7 and Poly-ICLC Administered Concomitantly in Cervical Intraepithelial Neoplasia (CIN) Subjects |
| Lead sponsor | Nventa Biopharmaceuticals Corporation, Industry |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cervical Intraepithelial Neoplasia |
| Intervention type | Biological |
| Interventions | HspE7 and Poly-ICLC |
| Enrollment | 24 |
| Start date | May 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jun 28, 2007 |
| Last update posted | May 7, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: